Cobalt_NN
chloride-induced_JJ
signaling_NN
in_IN
endothelium_NN
leading_VBG
to_TO
the_DT
augmented_JJ
adherence_NN
of_IN
sickle_JJ
red_JJ
blood_NN
cells_NNS
and_CC
transendothelial_JJ
migration_NN
of_IN
monocyte-like_JJ
HL-60_NN
cells_NNS
is_VBZ
blocked_VBN
by_IN
PAF-receptor_NN
antagonist_NN
._.

In_IN
response_NN
to_TO
hypoxia_NN
,_,
sickle_JJ
red_JJ
blood_NN
cells_NNS
-LRB-_-LRB-
SS_NN
RBC_NN
-RRB-_-RRB-
and_CC
leukocytes_NNS
exhibit_VBP
increased_VBN
adherence_NN
to_TO
the_DT
vascular_JJ
endothelium_NN
,_,
while_IN
diapedesis_NN
of_IN
leukocytes_NNS
through_IN
the_DT
blood_NN
vessel_NN
increases_VBZ
._.

However_RB
,_,
the_DT
cellular_JJ
signaling_VBG
pathway_NN
-LRB-_-LRB-
s_NNS
-RRB-_-RRB-
caused_VBN
by_IN
hypoxia_NN
is_VBZ
poorly_RB
understood_VBN
._.

We_PRP
utilized_VBD
CoCl2_NN
as_IN
a_DT
mimetic_JJ
molecule_NN
for_IN
hypoxia_NN
to_TO
study_VB
cellular_JJ
signaling_NN
pathways_NNS
._.

We_PRP
found_VBD
that_IN
in_IN
human_JJ
umbilical_JJ
vein_NN
endothelial_JJ
cells_NNS
-LRB-_-LRB-
HUVEC_NN
-RRB-_-RRB-
,_,
CoCl2_NN
at_IN
2_CD
mM_NN
concentration_NN
induced_VBD
the_DT
surface_NN
expression_NN
of_IN
a_DT
subset_NN
of_IN
CAMs_NNS
-LRB-_-LRB-
VCAM-1_NN
-RRB-_-RRB-
and_CC
activation_NN
of_IN
transcription_NN
factor_NN
NF-kappaB_NN
in_IN
the_DT
nuclear_JJ
extracts_NNS
of_IN
HUVEC_NN
._.

Furthermore_RB
,_,
CoCl2_NN
also_RB
caused_VBD
time-dependent_JJ
tyrosine_NN
phosphorylation_NN
of_IN
mitogen-activated_JJ
protein_NN
-LRB-_-LRB-
MAP_NN
-RRB-_-RRB-
kinase_NN
isoform_NN
ERK2_NN
without_IN
significantly_RB
affecting_VBG
ERK1_NN
,_,
indicating_VBG
ERK2_NN
is_VBZ
the_DT
preferred_JJ
substrate_NN
for_IN
upstream_JJ
kinase_NN
of_IN
the_DT
MAPK_NN
pathway_NN
._.

Inhibitors_NNS
of_IN
MAP_NN
kinase_NN
-LRB-_-LRB-
PD98059_NN
-RRB-_-RRB-
or_CC
platelet-activating_JJ
factor_NN
-LRB-_-LRB-
PAF_NN
-RRB-_-RRB-
-_:
receptor_NN
antagonist_NN
-LRB-_-LRB-
CV3988_NN
-RRB-_-RRB-
inhibited_VBD
the_DT
CoCl2-induced_JJ
NF-kappaB_NN
activation_NN
and_CC
VCAM-1_NN
expression_NN
._.

Augmented_JJ
expression_NN
of_IN
VCAM-1_NN
led_VBD
to_TO
increased_VBN
SS_NN
RBC_NN
adhesion_NN
,_,
inhibitable_JJ
by_IN
a_DT
VCAM-1_NN
antibody_NN
._.

Additionally_RB
,_,
CoCl2_NN
caused_VBD
a_DT
two_CD
-_:
to_TO
threefold_RB
increase_VB
in_IN
the_DT
rate_NN
of_IN
transendothelial_JJ
migration_NN
of_IN
monocyte-like_JJ
HL-60_NN
cells_NNS
and_CC
a_DT
twentyfold_JJ
increase_NN
in_IN
phosphorylation_NN
of_IN
platelet_NN
endothelial_JJ
cell_NN
adhesion_NN
molecules_NNS
-LRB-_-LRB-
PECAM-1_NN
-RRB-_-RRB-
._.

The_DT
transendothelial_JJ
migration_NN
of_IN
monocytes_NNS
was_VBD
inhibited_VBN
by_IN
an_DT
antibody_NN
to_TO
PECAM-1_NN
._.

Both_DT
phosphorylation_NN
of_IN
PECAM-1_NN
and_CC
transendothelial_JJ
migration_NN
of_IN
monocytes_NNS
in_IN
response_NN
to_TO
CoCl2_NN
were_VBD
inhibited_VBN
by_IN
protein_NN
kinase_NN
inhibitor_NN
-LRB-_-LRB-
GF109203X_NN
-RRB-_-RRB-
and_CC
augmented_JJ
by_IN
protein_NN
phosphatase_NN
inhibitor_NN
-LRB-_-LRB-
Calyculin_NN
A_NN
-RRB-_-RRB-
._.

Our_PRP$
data_NNS
suggests_VBZ
that_IN
CoCl2-induced_JJ
cellular_JJ
signals_NNS
directing_VBG
increased_VBN
expression_NN
of_IN
VCAM-1_NN
in_IN
HUVEC_NN
involve_VBP
downstream_JJ
activation_NN
of_IN
MAP_NN
kinase_NN
and_CC
NF-kappaB_NN
,_,
while_IN
the_DT
phosphorylation_NN
of_IN
PECAM-1_NN
occurs_VBZ
as_IN
a_DT
result_NN
of_IN
activation_NN
of_IN
PKC_NN
._.

We_PRP
conclude_VBP
that_IN
PAF-receptor_NN
antagonist_NN
inhibits_VBZ
the_DT
CoCl2_NN
-_:
or_CC
hypoxia-induced_JJ
increase_NN
in_IN
the_DT
adhesion_NN
of_IN
SS_NN
RBC_NNS
,_,
PECAM-1_NN
phosphorylation_NN
,_,
and_CC
the_DT
concomitant_JJ
transendothelial_JJ
migration_NN
of_IN
monocytes_NNS
._.

